Thu 17 Sep 2026 International edition
♥ Support Us
Clinical Trials & Research Neurocrine begins Phase I trial of NBIP-‘1968 triple agonist for obesity
Bio-Research & Life Sciences Challenging Oceanography’s Oldest Dogmas: How Ancient Sediments Rewrite the Rules of Global Climate Circulation
Toxicology & Pharmacology Dietary Breakthrough: Yeast-Based Supplement Restores Anti-Tumor Immunity in Obese Models, Opening New Avenues for Cancer Therapy
Medical Devices & Lab Automation Electroninks and SIIX expand additive EMI shielding work
Bio-Research & Life Sciences Artificial Intelligence Unveils a Global Tide: AI-Driven Study Reveals Unprecedented Expansion of Floating Algae Across the World’s Oceans
Public Health & Epidemiology Global Study of 80,000 Older Adults Reveals Childhood Poverty Leaves a Lifelong Imprint on Healthy Aging
Medical Devices & Lab Automation Bridging the Diagnostic Divide: How Dopl Technologies is Revolutionizing Remote Care with Telerobotic Ultrasound
Clinical Diagnostics The Algorithmic Diagnostic Frontier: Pathology Leaders Weigh the Promise and Perils of AI-Driven Laboratories
Toxicology & Pharmacology Unlocking the Biology of Statin Intolerance: McMaster Researchers Discover the Immune-Metabolic Link Behind Muscle Pain
Precision Medicine Decoding the Blueprint of Sight: Johns Hopkins Researchers Uncover How Fetal Retinas Form Sharp Central Vision
Hematology & Blood Research Executive Overview
Clinical Trials & Research Akeso Doses First Patient in Landmark Phase II Trial Evaluating Novel AK146D1 and Ivonescimab Combination for Advanced Breast Cancer

Section 1

Section 2

Section 3

Section 4

Archive

Tag: advances